However, this massive gray-market loophole has allowed an explosion of underground wellness clinics, cosmetic spas, and fitness influencers to actively, and illegally, market these unregulated injectables for therapeutic use
There is limited high-quality clinical research evaluating its safety, especially for long-term or repeated use
This class of drugs mimics a hormone called glucagon-like peptide 1 (GLP-1)
Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
Dr Kelly says while these online promotions have been building for a couple of years, social media has accelerated them and made it easier to market the products directly to consumers
Neuroscience 39, 151170